These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6449360)

  • 41. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Latamoxef versus carbenicillin plus gentamicin or carbenicillin plus mecillinam in leukopenic, febrile patients with solid tumors.
    Hansen SW; Friis H; Ernst P; Vejlsgaard R; Hansen HH
    Acta Med Scand; 1986; 220(3):249-54. PubMed ID: 3535399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of mezlocillin and carbenicillin.
    Pancoast SJ; Neu HC
    Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin.
    Van Wingerden GI; Lolans V; Jackson GG
    J Bone Joint Surg Am; 1974 Oct; 56(7):1452-8. PubMed ID: 4215436
    [No Abstract]   [Full Text] [Related]  

  • 45. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
    Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
    Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies with azlocillin, mezlocillin, penicillin-g-potassium and sisomicin on tolerance in the cornea and the kinetics of inhibiting concentrations in the cornea and aqueous humor in rabbits].
    Gauri KK; Finck J; Claussen B; Schassan HH; Fedder J; Weuta H
    Infection; 1982; 10 Suppl 3():S221-6. PubMed ID: 6218119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cephalothin, carbenicillin, and gentamicin combination therapy for febrile patients with acute non-lymphocytic leukemia.
    Bloomfield CD; Kennedy BJ
    Cancer; 1974 Aug; 34(2):431-7. PubMed ID: 4850936
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative clinical evaluation of mezlocillin and carbenicillin.
    Sabbaj J; Torres M; Estrada R
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():121-4. PubMed ID: 6210659
    [No Abstract]   [Full Text] [Related]  

  • 49. Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
    Santini G; Carella AM; Bacigalupo A; Van Lint MT; Congiu AM; Occhini D; Costa G; Sbaffi A; Accornero L; Sciutto C
    Tumori; 1984 Apr; 70(2):151-8. PubMed ID: 6328716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
    Pater JL; Weir L
    J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative studies of mezlocillin, carbenicillin and ampicillin in the treatment of acute pelvic infection.
    Poindexter AN
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():159-61. PubMed ID: 6210663
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins.
    Rosenkranz H; Förster D
    Infection; 1979; 7(3):102-8. PubMed ID: 478650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
    Gaya H; Klastersky J; Schimpff SC; Tattersall MH
    Eur J Cancer (1965); 1975 Aug; 11suppl():1-4. PubMed ID: 767118
    [No Abstract]   [Full Text] [Related]  

  • 54. Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Moody MR; Young VM; Wiernik PH
    Antimicrob Agents Chemother; 1980 Aug; 18(2):299-306. PubMed ID: 6449902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Laboratory methods of controlling the effectiveness of antibacterial therapy].
    Treskina OS; Levina EN; Slepchenko LM
    Antibiot Med Biotekhnol; 1985 Jun; 30(6):456-9. PubMed ID: 4062272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience of mezlocillin in immunocompromised patients.
    Meunier-Carpentier F; Klastersky J
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():223-6. PubMed ID: 6210669
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacokinetic investigations on sisomicin in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter J
    Monatsschr Kinderheilkd (1902); 1978 Aug; 126(8):512-7. PubMed ID: 683201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.
    Norden CW
    J Infect Dis; 1978 Feb; 137(2):155-60. PubMed ID: 627735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis.
    Ballard JO; Barnes SG; Sattler FR
    Antimicrob Agents Chemother; 1984 Feb; 25(2):153-6. PubMed ID: 6712199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro study on the combined effect of mezlocillin and sisomicin on clinically pathogenic P. aeruginosa and E. coli].
    Shishido H; Mochinaga S; Matsumoto K
    Jpn J Antibiot; 1985 Jun; 38(6):1529-32. PubMed ID: 3930805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.